Autolus Therapeutics (AUTL)
(Delayed Data from NSDQ)
$3.50 USD
-0.23 (-6.17%)
Updated Sep 23, 2024 03:59 PM ET
After-Market: $3.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.21 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | -15.79% |
ABR | 1.38 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.84 |
Next Year | -0.70 |
EPS (TTM) | -1.16 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.40M | 0.30M | 10.29M | 70.06M |
# of Estimates | 1 | 1 | 4 | 4 |
High Estimate | 0.40M | 0.30M | 10.70M | 109.50M |
Low Estimate | 0.40M | 0.30M | 10.09M | 34.76M |
Year ago Sales | 0.41M | 0.00M | 1.70M | 10.29M |
Year over Year Growth Est. | -2.44% | NA | 505.72% | 581.22% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.21 | -0.18 | -0.84 | -0.70 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.22 | -0.25 | -0.92 | -0.93 |
High Estimate | -0.19 | -0.08 | -0.68 | -0.48 |
Low Estimate | -0.22 | -0.25 | -0.92 | -0.93 |
Year ago EPS | -0.26 | -0.44 | -1.20 | -0.84 |
Year over Year Growth Est. | 19.23% | 59.09% | 30.00% | 15.87% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 3 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.21 | -0.18 | -0.84 | -0.70 |
7 Days Ago | -0.21 | -0.18 | -0.84 | -0.70 |
30 Days Ago | -0.21 | -0.18 | -0.84 | -0.70 |
60 Days Ago | -0.20 | -0.16 | -0.78 | -0.62 |
90 Days Ago | -0.20 | -0.16 | -0.78 | -0.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.21 | -0.18 | -0.84 | -0.70 |
Zacks Consensus Estimate | -0.21 | -0.18 | -0.84 | -0.70 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.24 | -0.44 | -0.26 | NA |
Estimate | -0.19 | -0.10 | -0.26 | -0.24 | NA |
Difference | -0.03 | -0.14 | -0.18 | -0.02 | -0.09 |
Surprise | -15.79% | -140.00% | -69.23% | -8.33% | -58.34% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more